MITC welcomes partnerships with industry organizations seeking access to advanced molecular imaging resources, radiopharmaceutical expertise and translational research infrastructure. The center’s collaborative model is designed to support innovation from early discovery through preclinical development and toward clinical translation.

Through its connections with key research and clinical assets across the University of Missouri, MITC provides a coordinated environment for developing, evaluating and advancing new imaging agents and theranostic approaches. Industry collaborators can engage with a center built to accelerate discovery, strengthen study design and support the development of solutions with meaningful potential for patient care.